Con:Raisescost forconsumersID&E: Couldcreateglobaldisparities❌Con:Stiflessmallercompetitors🌎ID&E:Could createglobaldisparitiesCon:Potential jobloss insmaller firmsEdwardsLifesciencesCon:ReducescompetitionJenaValveID&E:Increasesaccess tolife-savingdevices🌎ID&E:RegulatoryoversightprotectsfairnessCon: Riskof marketmonopolyPro:ExpandstreatmentoptionsID&E:Opportunityto designfor inclusion“Innovation”Pro:Createscompetitiveadvantage✅Pro:EncouragesefficiencyHeartWareThoratecID&E:Regulatoryoversightprotectsfairness🌎ID&E:Increasesaccess tolife-savingdevices🌎ID&E:May reduceequitableaccess ifcosts rise🌎ID&E:Opportunityto designfor inclusion✅Pro:Lowerslong-termcosts❌Con:Antitrustchallenges✅Pro:Promotesfasterdevelopment✅Pro:Improvespatientoutcomes🌎ID&E:Impactsaffordability forunderservedpopulations❌Con:Risk ofmarketmonopolyCon: StiflessmallercompetitorsID&E:ImpactsaffordabilityforunderservedpopulationsPro:EncouragesefficiencyCon:AntitrustchallengesTAVR-ARdevicePro:Promotesfasterdevelopment“CaseStudyMentioned”❌Con:Raisescost forconsumersID&E: Riskof bias intechnologyadoptionPro:Lowerslong-termcosts“Antitrust”“CaseStudyMentioned”✅Pro:CreatescompetitiveadvantagePro:ImprovespatientoutcomesCon: Canlimitinnovation (ifmonopolized)✅Pro:Drivesinnovation“Innovation”Pro:Drivesinnovation❌Con: Canlimitinnovation (ifmonopolized)✅Pro:Expandstreatmentoptions❌Con:Reducescompetition“Antitrust”🌎ID&E:Risk of biasintechnologyadoption❌Con:Potential jobloss insmaller firmsID&E: Mayreduceequitableaccess ifcosts riseCon:Raisescost forconsumersID&E: Couldcreateglobaldisparities❌Con:Stiflessmallercompetitors🌎ID&E:Could createglobaldisparitiesCon:Potential jobloss insmaller firmsEdwardsLifesciencesCon:ReducescompetitionJenaValveID&E:Increasesaccess tolife-savingdevices🌎ID&E:RegulatoryoversightprotectsfairnessCon: Riskof marketmonopolyPro:ExpandstreatmentoptionsID&E:Opportunityto designfor inclusion“Innovation”Pro:Createscompetitiveadvantage✅Pro:EncouragesefficiencyHeartWareThoratecID&E:Regulatoryoversightprotectsfairness🌎ID&E:Increasesaccess tolife-savingdevices🌎ID&E:May reduceequitableaccess ifcosts rise🌎ID&E:Opportunityto designfor inclusion✅Pro:Lowerslong-termcosts❌Con:Antitrustchallenges✅Pro:Promotesfasterdevelopment✅Pro:Improvespatientoutcomes🌎ID&E:Impactsaffordability forunderservedpopulations❌Con:Risk ofmarketmonopolyCon: StiflessmallercompetitorsID&E:ImpactsaffordabilityforunderservedpopulationsPro:EncouragesefficiencyCon:AntitrustchallengesTAVR-ARdevicePro:Promotesfasterdevelopment“CaseStudyMentioned”❌Con:Raisescost forconsumersID&E: Riskof bias intechnologyadoptionPro:Lowerslong-termcosts“Antitrust”“CaseStudyMentioned”✅Pro:CreatescompetitiveadvantagePro:ImprovespatientoutcomesCon: Canlimitinnovation (ifmonopolized)✅Pro:Drivesinnovation“Innovation”Pro:Drivesinnovation❌Con: Canlimitinnovation (ifmonopolized)✅Pro:Expandstreatmentoptions❌Con:Reducescompetition“Antitrust”🌎ID&E:Risk of biasintechnologyadoption❌Con:Potential jobloss insmaller firmsID&E: Mayreduceequitableaccess ifcosts rise

Competitive Technology - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
  1. Con: Raises cost for consumers
  2. ID&E: Could create global disparities
  3. ❌Con: Stifles smaller competitors
  4. 🌎ID&E: Could create global disparities
  5. Con: Potential job loss in smaller firms
  6. Edwards Lifesciences
  7. Con: Reduces competition
  8. JenaValve
  9. ID&E: Increases access to life-saving devices
  10. 🌎ID&E: Regulatory oversight protects fairness
  11. Con: Risk of market monopoly
  12. Pro: Expands treatment options
  13. ID&E: Opportunity to design for inclusion
  14. “Innovation”
  15. Pro: Creates competitive advantage
  16. ✅Pro: Encourages efficiency
  17. HeartWare
  18. Thoratec
  19. ID&E: Regulatory oversight protects fairness
  20. 🌎ID&E: Increases access to life-saving devices
  21. 🌎ID&E: May reduce equitable access if costs rise
  22. 🌎ID&E: Opportunity to design for inclusion
  23. ✅Pro: Lowers long-term costs
  24. ❌Con: Antitrust challenges
  25. ✅Pro: Promotes faster development
  26. ✅Pro: Improves patient outcomes
  27. 🌎ID&E:Impacts affordability for underserved populations
  28. ❌Con: Risk of market monopoly
  29. Con: Stifles smaller competitors
  30. ID&E:Impacts affordability for underserved populations
  31. Pro: Encourages efficiency
  32. Con: Antitrust challenges
  33. TAVR-AR device
  34. Pro: Promotes faster development
  35. “Case Study Mentioned”
  36. ❌Con: Raises cost for consumers
  37. ID&E: Risk of bias in technology adoption
  38. Pro: Lowers long-term costs
  39. “Antitrust”
  40. “Case Study Mentioned”
  41. ✅Pro: Creates competitive advantage
  42. Pro: Improves patient outcomes
  43. Con: Can limit innovation (if monopolized)
  44. ✅Pro: Drives innovation
  45. “Innovation”
  46. Pro: Drives innovation
  47. ❌Con: Can limit innovation (if monopolized)
  48. ✅Pro: Expands treatment options
  49. ❌Con: Reduces competition
  50. “Antitrust”
  51. 🌎ID&E: Risk of bias in technology adoption
  52. ❌Con: Potential job loss in smaller firms
  53. ID&E: May reduce equitable access if costs rise